Request for Applications: MATRIX Technology Accelerator Domain 1

Microbicide R&D to Advance HIV Prevention Technologies through Responsive Innovation and eXcellence (MATRIX)  is  seeking innovative research applications for the development of new HIV prevention drug and strategies, multipurpose prevention technologies (MPTs), and technologies that enable HIV prevention strategy development and have the potential to strengthen capacity in targeted countries. Established researchers, research consortia, students, postdoctoral fellows, and new investigators establishing laboratories and/or seeking tenure from the United States, European Union, United Kingdom, Kenya, South Africa, and Zimbabwe are encouraged to apply.

Proposed research must be driven by milestones, go/no-go criteria, and timelines, and must target development of HIV prevention for one or more of the following populations: adolescent girls and young women, pregnant and breastfeeding people, and female sex workers.

Applications are limited to projects with costs of US$150,000 and a duration of 18 months.

Click here for instructions on how to apply. 

Key Dates: 

Letter of intent due: February 22, 2024 (8:00AM Pacific time)

Fact-finding questions due: February 22, 2024 (8:00AM Pacific time)

Responses to fact-finding questions provided to applicants: March 1, 2024 (8:00AM Pacific time)

Applications due April 1, 2024 (8:00AM Pacific time)

Estimated decision notification: May 15, 2024

Estimated project start date: July 1, 2024